Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025
Vaxart, Inc. (OTCQX: VXRT) (“Vaxart”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it ...
A live webcast and additional information about the presentation can be accessed on the Events & Presentations section of the Phathom website at ...
Atlantic Importing Company is a premier Southern New England distributor offering a wide portfolio of beverages, craft brands, and specialty foods. With deep local expertise and a commitment to ...
Reverba Global, a leader in scientific engagement for biopharma companies, today announced the launch of ClinOps G.P.S.™ (Global Performance Solution), an operations platform of integrated technology ...
Adaptyx Biosciences, a biowearables company developing the first platform for continuous, multi-analyte molecular monitoring, today announced it has raised $14 million in seed financing, bringing ...
H.C. Wainwright 9th Annual MASH Investor Conference Company presentation: October 21, 2025, at 7:00 AM ET Webcast: here The live and archived webcast will also be available on the Events & ...
These upcoming presentations underscore the breadth and versatility of our ACT-UP1 platform,” said Xuehai Liang, Ph.D., Chief Executive Officer of Arnatar Therapeutics. “By demonstrating the ability ...
VLTR-559 was well tolerated at target clinical dose with a safety profile similar to approved short-acting anti-VEGF therapies for wet AMD Data featured in an oral presentation at the at the ...
The event will take place on November 3, 2025 beginning at 10 am ET and will feature presentations by ProQR Management and Key Opinion Leader Professor Henkjan J. Verkade, MD, PhD, a pediatric ...
R1 (“R1” or the “Company”), the leader in healthcare revenue management, today announced a strategic partnership with Sierra, the leading AI-powered customer experience platform. This partnership ...
The live webcasts can be accessed in the events section of the MBX Biosciences website at https://investors.mbxbio.com/news-events/events. Access to the webcast replays will be available approximately ...
The webcast and replay of the presentation will be accessible in the Investor section of the CervoMed website https://www.cervomed.com/.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback